Bristol-Myers Squibb Co (NYSE:BMY)
| 62.64 BATS BZX Real-Time Price As of 1:49pm ET |  +0.18 / +0.29%Today’s Change | 53.22 Today|||52-Week Range 69.75 | +0.47% Year-to-Date |
Latest BMY News | Press Releases
Today’s Trading
| Previous close | 62.46 |
| Today’s open | 62.38 |
| Day’s range | 62.26 - 63.40 |
| Volume | 4,638,582 |
| Average volume (3 months) | 12,850,880 |
| Market cap | $141.0B |
Data as of 1:49pm ET, 01/26/2022
Growth & Valuation
| Earnings growth (last year) | -297.94% |
| Earnings growth (this year) | +16.21% |
| Earnings growth (next 5 years) | +7.70% |
| Revenue growth (last year) | +62.62% |
| P/E ratio | NM |
| Price/Sales | 3.29 |
| Price/Book | 3.77 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNYSanofi | +0.28 | +0.54% |
| NVONovo Nordisk | -0.66 | -0.69% |
| GSKGlaxoSmithKline | 0.00 | 0.00% |
| AZNAstraZeneca | -0.54 | -0.93% |
Data as of 1:50pm ET, 01/26/2022
Financials
| Next reporting date | February 4, 2022 |
| EPS forecast (this quarter) | $1.80 |
| Annual revenue (last year) | $42.5B |
| Annual profit (last year) | -$9.0B |
| Net profit margin | -21.20% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
